Sage to Lay Off Most Staff Amid Supernus Buyout

Sage to lay off most staff amid Supernus buyout

The biotech, which agreed to be bought by Supernus after clinical and commercial struggles, plans to lay off 338 employees by late August.

Sage Therapeutics cuts most of its workforce following acquisition

Maryland-based Supernus Pharmaceuticals said earlier this month that it would acquire Sage in a deal worth up to $795 million.

Sage plans to lay off almost every employee after inking Supernus deal

After announcing a buyer earlier this month, Sage Therapeutics now plans to lay off virtually all of its employees. The company disclosed the workforce reduction in a WARN notice in Massachusetts ...